'''Zolimomab aritox''' is a mouse [[monoclonal antibody]] which has been investigated for the treatment of [[systemic lupus erythematosus]]<ref>{{cite journal|pmid=7532717|year=1994|last1=Stafford|first1=FJ|last2=Fleisher|first2=TA|last3=Lee|first3=G|last4=Brown|first4=M|last5=Strand|first5=V|last6=Austin Ha|first6=3rd|last7=Balow|first7=JE|last8=Klippel|first8=JH|title=A pilot study of anti-CD5 ricin a chain immunoconjugate in systemic lupus erythematosus|volume=21|issue=11|pages=2068–70|journal=The Journal of rheumatology}}</ref> and [[graft-versus-host disease]],<ref>{{cite journal|pmid=7584486|year=1994|last1=Przepiorka|first1=D|last2=Lemaistre|first2=CF|last3=Huh|first3=YO|last4=Luna|first4=M|last5=Saria|first5=EA|last6=Brown|first6=CT|last7=Champlin|first7=RE|title=Evaluation of anti-CD5 ricin a chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation|volume=1|issue=2|pages=77–82|journal=Therapeutic immunology}}</ref> but the studies failed to show positive effects of the drug.
